| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2024 ( Subtotal = $73,089,555 ) (Continued on the next page) |
| | 2024 | 2024 | BECKMAN RESEARCH INSTITUTE OF THE CITY OF HOPE | 1500 DUARTE RD | DUARTE | CA | 91010-3012 | LOS ANGELES | USA | R50CA252135 | Improving Outcomes for Multiple Myeloma Patients through Novel Therapeutic Interventions | 000 | 4 | NIH | 8/13/2024 | $112,893 |
| | 2024 | 2024 | BECKMAN RESEARCH INSTITUTE OF THE CITY OF HOPE | 1500 DUARTE RD | DUARTE | CA | 91010-3012 | LOS ANGELES | USA | U19CA264512 | Development of Small Molecule Inhibitors and Biologic Agents for Treatment of Glioblastoma Using Intracerebral Microdialysis and Signatures of Vulnerability | 003 | 4 | NIH | 9/5/2024 | $882,648 |
| | 2024 | 2024 | BECKMAN RESEARCH INSTITUTE OF THE CITY OF HOPE | 1500 DUARTE RD | DUARTE | CA | 91010-3012 | LOS ANGELES | USA | R01CA255250 | Identifying and engaging a universal adjuvant for breaking macrophage immune tolerance in cancer | 000 | 4 | NIH | 6/14/2024 | $409,926 |
| | 2024 | 2024 | BECKMAN RESEARCH INSTITUTE OF THE CITY OF HOPE | 1500 DUARTE RD | DUARTE | CA | 91010-3012 | LOS ANGELES | USA | R01CA264911 | Unmasking the roles of viral glycoproteins in oral transmission of KSHV | 001 | 4 | NIH | 8/28/2024 | $75,469 |
| | 2024 | 2024 | BECKMAN RESEARCH INSTITUTE OF THE CITY OF HOPE | 1500 DUARTE RD | DUARTE | CA | 91010-3012 | LOS ANGELES | USA | R01CA264911 | Unmasking the roles of viral glycoproteins in oral transmission of KSHV | 000 | 4 | NIH | 8/15/2024 | $840,321 |
| | 2024 | 2024 | BECKMAN RESEARCH INSTITUTE OF THE CITY OF HOPE | 1500 DUARTE RD | DUARTE | CA | 91010-3012 | LOS ANGELES | USA | R01AI151013 | KSHV Subunit Vaccine Candidates to Elicit Potent Humoral Immune Reponses against KSHV Infection | 001 | 4 | NIH | 5/23/2024 | $84,892 |
| | 2024 | 2024 | BECKMAN RESEARCH INSTITUTE OF THE CITY OF HOPE | 1500 DUARTE RD | DUARTE | CA | 91010-3012 | LOS ANGELES | USA | R01AI151013 | KSHV Subunit Vaccine Candidates to Elicit Potent Humoral Immune Reponses against KSHV Infection | 000 | 4 | NIH | 2/1/2024 | $764,036 |
| | 2024 | 2024 | BECKMAN RESEARCH INSTITUTE OF THE CITY OF HOPE | 1500 DUARTE RD | DUARTE | CA | 91010-3012 | LOS ANGELES | USA | R01DK125856 | Circulating Extracellular Vesicles in the Pathogenesis of Type 1 Diabetes | 000 | 4 | NIH | 6/14/2024 | $443,154 |
| | 2024 | 2024 | BECKMAN RESEARCH INSTITUTE OF THE CITY OF HOPE | 1500 DUARTE RD | DUARTE | CA | 91010-3012 | LOS ANGELES | USA | R01CA265095 | Targeting FLT3 for the Treatment of Relapsed or Refractory Acute Myeloid Leukemia | 000 | 4 | NIH | 8/16/2024 | $464,700 |
| | 2024 | 2024 | BECKMAN RESEARCH INSTITUTE OF THE CITY OF HOPE | 1500 DUARTE RD | DUARTE | CA | 91010-3012 | LOS ANGELES | USA | R01DK126975 | The Role of Adipocyte Uridine Biosynthesis in Obesity and Diabetes Progression | 000 | 5 | NIH | 7/31/2024 | $422,400 |
| | 2024 | 2024 | BECKMAN RESEARCH INSTITUTE OF THE CITY OF HOPE | 1500 DUARTE RD | DUARTE | CA | 91010-3012 | LOS ANGELES | USA | R01CA254271 | Clinical Evaluation of Chlorotoxin-redirected Chimeric Antigen Receptor (CAR) T cells for Treatment of Glioblastoma | 000 | 5 | NIH | 4/11/2024 | $711,759 |
| | 2024 | 2024 | BECKMAN RESEARCH INSTITUTE OF THE CITY OF HOPE | 1500 DUARTE RD | DUARTE | CA | 91010-3012 | LOS ANGELES | USA | R01AI146313 | The role of miR-142 in regulatory T cell Development and function | 000 | 5 | NIH | 8/16/2024 | $440,000 |
| | 2024 | 2024 | BECKMAN RESEARCH INSTITUTE OF THE CITY OF HOPE | 1500 DUARTE RD | DUARTE | CA | 91010-3012 | LOS ANGELES | USA | R01CA262754 | The role of CEACAM1 in oncogenic B-cell receptor signaling and immunotherapy in mantle cell lymphoma | 000 | 4 | NIH | 6/28/2024 | $381,482 |
| | 2024 | 2024 | BECKMAN RESEARCH INSTITUTE OF THE CITY OF HOPE | 1500 DUARTE RD | DUARTE | CA | 91010-3012 | LOS ANGELES | USA | R01HD096152 | Mammary Adipocyte Remodeling in Health and Disease | 000 | 5 | NIH | 2/16/2024 | $333,749 |
| | 2024 | 2024 | BECKMAN RESEARCH INSTITUTE OF THE CITY OF HOPE | 1500 DUARTE RD | DUARTE | CA | 91010-3012 | LOS ANGELES | USA | R01CA249460 | Technology-Enabled Activation of Skin Cancer Screening for Hematopoietic Cell Transplantation Survivors and their Primary Care Providers | 001 | 5 | NIH | 4/16/2024 | $39,410 |
| | 2024 | 2024 | BECKMAN RESEARCH INSTITUTE OF THE CITY OF HOPE | 1500 DUARTE RD | DUARTE | CA | 91010-3012 | LOS ANGELES | USA | R01CA249460 | Technology-Enabled Activation of Skin Cancer Screening for Hematopoietic Cell Transplantation Survivors and their Primary Care Providers | 000 | 5 | NIH | 3/11/2024 | $709,370 |
| | 2024 | 2024 | BECKMAN RESEARCH INSTITUTE OF THE CITY OF HOPE | 1500 DUARTE RD | DUARTE | CA | 91010-3012 | LOS ANGELES | USA | R01DK124627 | Bile acids and metabolic surgery | 000 | 5 | NIH | 5/31/2024 | $380,160 |
| | 2024 | 2024 | BECKMAN RESEARCH INSTITUTE OF THE CITY OF HOPE | 1500 DUARTE RD | DUARTE | CA | 91010-3012 | LOS ANGELES | USA | U01CA250046 | Information flow and state transitions at the system and multi-dimensional scales in leukemia progression | 000 | 5 | NIH | 4/30/2024 | $623,198 |
| | 2024 | 2024 | BECKMAN RESEARCH INSTITUTE OF THE CITY OF HOPE | 1500 DUARTE RD | DUARTE | CA | 91010-3012 | LOS ANGELES | USA | R33AG059206 | Geriatric Oncology Research Infrastructure to Improve Clinical Care | 002 | 7 | NIH | 6/27/2024 | $631,571 |
| | 2024 | 2024 | BECKMAN RESEARCH INSTITUTE OF THE CITY OF HOPE | 1500 DUARTE RD | DUARTE | CA | 91010-3012 | LOS ANGELES | USA | K08CA252157 | Multi-antigen-specific CAR T cells to treat acute myeloid leukemia | 001 | 5 | NIH | 8/30/2024 | $263,034 |
| | 2024 | 2024 | BECKMAN RESEARCH INSTITUTE OF THE CITY OF HOPE | 1500 DUARTE RD | DUARTE | CA | 91010-3012 | LOS ANGELES | USA | R01CA246553 | Developing BRAF mutant and BRAF wild-type selective strategies for radiosensitization in Anaplastic Thyroid Cancer | 000 | 5 | NIH | 8/1/2024 | $194,528 |
| | 2024 | 2024 | BECKMAN RESEARCH INSTITUTE OF THE CITY OF HOPE | 1500 DUARTE RD | DUARTE | CA | 91010-3012 | LOS ANGELES | USA | R01CA248475 | Vascular Remodeling in the Bone Marrow Leukemic Niche: A Therapeutic Target? | 001 | 5 | NIH | 4/18/2024 | $25,529 |
| | 2024 | 2024 | BECKMAN RESEARCH INSTITUTE OF THE CITY OF HOPE | 1500 DUARTE RD | DUARTE | CA | 91010-3012 | LOS ANGELES | USA | R01CA248475 | Vascular Remodeling in the Bone Marrow Leukemic Niche: A Therapeutic Target? | 000 | 5 | NIH | 3/14/2024 | $459,519 |
| | 2024 | 2024 | BECKMAN RESEARCH INSTITUTE OF THE CITY OF HOPE | 1500 DUARTE RD | DUARTE | CA | 91010-3012 | LOS ANGELES | USA | R01CA248149 | Role of Protein Arginine Methyltransferase 9 in Acute Myeloid Leukemia Maintenance | 001 | 5 | NIH | 4/18/2024 | $21,676 |
| | 2024 | 2024 | BECKMAN RESEARCH INSTITUTE OF THE CITY OF HOPE | 1500 DUARTE RD | DUARTE | CA | 91010-3012 | LOS ANGELES | USA | R01CA248149 | Role of Protein Arginine Methyltransferase 9 in Acute Myeloid Leukemia Maintenance | 000 | 5 | NIH | 2/19/2024 | $390,165 |
| | 2024 | 2024 | BECKMAN RESEARCH INSTITUTE OF THE CITY OF HOPE | 1500 DUARTE RD | DUARTE | CA | 91010-3012 | LOS ANGELES | USA | R01CA240910 | Cooperation of SF3B1 mutations and ATM deletions in the pathogenesis of chronic lymphocytic leukemia | 001 | 5 | NIH | 4/18/2024 | $21,183 |
| | 2024 | 2024 | BECKMAN RESEARCH INSTITUTE OF THE CITY OF HOPE | 1500 DUARTE RD | DUARTE | CA | 91010-3012 | LOS ANGELES | USA | R01CA240910 | Cooperation of SF3B1 mutations and ATM deletions in the pathogenesis of chronic lymphocytic leukemia | 000 | 5 | NIH | 4/1/2024 | $381,301 |
| | 2024 | 2024 | BECKMAN RESEARCH INSTITUTE OF THE CITY OF HOPE | 1500 DUARTE RD | DUARTE | CA | 91010-3012 | LOS ANGELES | USA | R25CA240111 | Interdisciplinary Communication Training in Oncology | 000 | 5 | NIH | 2/9/2024 | $203,109 |
| | 2024 | 2024 | BECKMAN RESEARCH INSTITUTE OF THE CITY OF HOPE | 1500 DUARTE RD | DUARTE | CA | 91010-3012 | LOS ANGELES | USA | R25CA240111 | Interdisciplinary Communication Training in Oncology | 001 | 5 | NIH | 4/18/2024 | $90,305 |
| | 2024 | 2024 | BECKMAN RESEARCH INSTITUTE OF THE CITY OF HOPE | 1500 DUARTE RD | DUARTE | CA | 91010-3012 | LOS ANGELES | USA | R01AG063854 | Defining the Role of Adipogenesis in Age-Associated Adiposity | 000 | 5 | NIH | 4/24/2024 | $360,800 |
| | 2024 | 2024 | BECKMAN RESEARCH INSTITUTE OF THE CITY OF HOPE | 1500 DUARTE RD | DUARTE | CA | 91010-3012 | LOS ANGELES | USA | T32CA221709 | Cancer Metabolism Training Program | 001 | 6 | NIH | 6/21/2024 | $248,089 |
| | 2024 | 2024 | BECKMAN RESEARCH INSTITUTE OF THE CITY OF HOPE | 1500 DUARTE RD | DUARTE | CA | 91010-3012 | LOS ANGELES | USA | R37CA233691 | Combinational Targeting the Feed-forward Epigenetic Circuitry in Mixed Lineage Leukemia | 001 | 6 | NIH | 6/6/2024 | $20,129 |
| | 2024 | 2024 | BECKMAN RESEARCH INSTITUTE OF THE CITY OF HOPE | 1500 DUARTE RD | DUARTE | CA | 91010-3012 | LOS ANGELES | USA | R37CA233691 | Combinational Targeting the Feed-forward Epigenetic Circuitry in Mixed Lineage Leukemia | 000 | 6 | NIH | 2/2/2024 | $362,340 |
| | 2024 | 2024 | BECKMAN RESEARCH INSTITUTE OF THE CITY OF HOPE | 1500 DUARTE RD | DUARTE | CA | 91010-3012 | LOS ANGELES | USA | U24DK104162 | Renewal of the Human Islet Research Enhancement Center (HIREC) for the Type-1-Diabetes-Focused Human Islet Research Network (HIRN). | 002 | 11 | NIH | 9/13/2024 | $0 |
| | 2024 | 2024 | BECKMAN RESEARCH INSTITUTE OF THE CITY OF HOPE | 1500 DUARTE RD | DUARTE | CA | 91010-3012 | LOS ANGELES | USA | U24DK104162 | Renewal of the Human Islet Research Enhancement Center (HIREC) for the Type-1-Diabetes-Focused Human Islet Research Network (HIRN). | 002 | 11 | NIH | 9/13/2024 | $0 |
| | 2024 | 2024 | BECKMAN RESEARCH INSTITUTE OF THE CITY OF HOPE | 1500 DUARTE RD | DUARTE | CA | 91010-3012 | LOS ANGELES | USA | U24DK104162 | Renewal of the Human Islet Research Enhancement Center (HIREC) for the Type-1-Diabetes-Focused Human Islet Research Network (HIRN). | 001 | 11 | NIH | 8/29/2024 | $500,000 |
| | 2024 | 2024 | BECKMAN RESEARCH INSTITUTE OF THE CITY OF HOPE | 1500 DUARTE RD | DUARTE | CA | 91010-3012 | LOS ANGELES | USA | U24DK104162 | Renewal of the Human Islet Research Enhancement Center (HIREC) for the Type-1-Diabetes-Focused Human Islet Research Network (HIRN). | 001 | 11 | NIH | 8/29/2024 | $1,112,983 |
| | 2024 | 2024 | BECKMAN RESEARCH INSTITUTE OF THE CITY OF HOPE | 1500 DUARTE RD | DUARTE | CA | 91010-3012 | LOS ANGELES | USA | R01CA228308 | The role of bile acid metabolomics in graft-versus-host disease | 004 | 7 | NIH | 9/9/2024 | $276,000 |
| | 2024 | 2024 | BECKMAN RESEARCH INSTITUTE OF THE CITY OF HOPE | 1500 DUARTE RD | DUARTE | CA | 91010-3012 | LOS ANGELES | USA | R01CA228308 | The role of bile acid metabolomics in graft-versus-host disease | 001 | 7 | NIH | 5/6/2024 | $555,619 |
| | 2024 | 2024 | BECKMAN RESEARCH INSTITUTE OF THE CITY OF HOPE | 1500 DUARTE RD | DUARTE | CA | 91010-3012 | LOS ANGELES | USA | R01HL137723 | Role of the unfolded protein response in pathological cardiac remodeling | 000 | 9 | NIH | 5/29/2024 | $563,886 |
| | 2024 | 2024 | BECKMAN RESEARCH INSTITUTE OF THE CITY OF HOPE | 1500 DUARTE RD | DUARTE | CA | 91010-3012 | LOS ANGELES | USA | UG1HL069278 | BMT CTN Core - City of Hope National Medical Center | 001 | 24 | NIH | 8/15/2024 | $264,000 |
| | 2024 | 2024 | BECKMAN RESEARCH INSTITUTE OF THE CITY OF HOPE | 1500 DUARTE RD | DUARTE | CA | 91010-3012 | LOS ANGELES | USA | U01CA214254 | Exosome-based microRNA biomarkers for Non-invasive and Early Detection of Pancreatic Cancer | 003 | 7 | NIH | 8/8/2024 | $815,080 |
| | 2024 | 2024 | BECKMAN RESEARCH INSTITUTE OF THE CITY OF HOPE | 1500 DUARTE RD | DUARTE | CA | 91010-3012 | LOS ANGELES | USA | R25CA217270 | Preparing Oncology Advanced Practice Nurses as Generalists in Palliative Care | 001 | 7 | NIH | 4/18/2024 | $32,399 |
| | 2024 | 2024 | BECKMAN RESEARCH INSTITUTE OF THE CITY OF HOPE | 1500 DUARTE RD | DUARTE | CA | 91010-3012 | LOS ANGELES | USA | R25CA217270 | Preparing Oncology Advanced Practice Nurses as Generalists in Palliative Care | 000 | 7 | NIH | 2/14/2024 | $291,600 |
| | 2024 | 2024 | BECKMAN RESEARCH INSTITUTE OF THE CITY OF HOPE | 1500 DUARTE RD | DUARTE | CA | 91010-3012 | LOS ANGELES | USA | R01CA205247 | Targeting MicroRNAs to Eradicate Leukemia Stem Cells | 000 | 8 | NIH | 7/15/2024 | $480,469 |
| | 2024 | 2024 | BECKMAN RESEARCH INSTITUTE OF THE CITY OF HOPE | 1500 DUARTE RD | DUARTE | CA | 91010-3012 | LOS ANGELES | USA | R01CA256989 | Elucidating the role of DNAPKcs in chromosomal break end joining and clastogen resistance | 002 | 4 | NIH | 6/26/2024 | $91,839 |
| | 2024 | 2024 | BECKMAN RESEARCH INSTITUTE OF THE CITY OF HOPE | 1500 DUARTE RD | DUARTE | CA | 91010-3012 | LOS ANGELES | USA | R01CA256989 | Elucidating the role of DNAPKcs in chromosomal break end joining and clastogen resistance | 001 | 4 | NIH | 6/25/2024 | $382,471 |
| | 2024 | 2024 | BECKMAN RESEARCH INSTITUTE OF THE CITY OF HOPE | 1500 DUARTE RD | DUARTE | CA | 91010-3012 | LOS ANGELES | USA | R01CA256989 | Elucidating the role of DNAPKcs in chromosomal break end joining and clastogen resistance | 000 | 3 | NIH | 3/6/2024 | $36,971 |
| | 2024 | 2024 | BECKMAN RESEARCH INSTITUTE OF THE CITY OF HOPE | 1500 DUARTE RD | DUARTE | CA | 91010-3012 | LOS ANGELES | USA | R35HG010721 | Scalable tools to effectively translate genomic discoveries into the clinic : Administrative Supplement | 001 | 5 | NIH | 8/22/2024 | $454,575 |
|
